Antipsychotic prescribing practices in the Veterans Healthcare Administration--New York metropolitan region.
about
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychoticsA translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacyAn audit of outpatient antipsychotic usage in the three health sectors of Auckland, New Zealand.Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study.Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia.Clozapine prescribing in the UK: views and experience of consultant psychiatrists.Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.Adding or switching antipsychotic medications in treatment-refractory schizophrenia.Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns.Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practiceTreatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.Choice of randomization to clozapine versus other second generation antipsychotics in the CATIE schizophrenia trialDoes antipsychotic polypharmacy increase the risk for metabolic syndrome?Polypharmacy in the management of patients with schizophrenia on risperidone in a tertiary-care hospital in MalaysiaExplicit versus implicit review to explore combination antipsychotic prescribing.Pharmacotherapy for treatment-refractory schizophrenia.Antipsychotic polypharmacy in schizophrenia: benefits and risks.Comparison of treatment patterns in schizophrenia between China and Japan (2001-2009).Trends in antipsychotic prescribing in schizophrenia in Auckland.The physical health of people with schizophrenia in Asia: Baseline findings from a physical health check programme.Antipsychotic Use Pattern in People with Psychotic Disorder Living in Board and Care Facilities.Prescribing practices of clozapine in India: Results of a opinion survey of psychiatrists.Switching to ziprasidone in the clinical practice setting: an open-label study.Current status of clozapine in the United States.Outcomes for schizophrenia patients with clozapine treatment: how good does it get?Benefit coverage of novel antipsychotics in Medicaid programs and the Veterans Health Administration.Trends in adult antipsychotic polypharmacy: progress and challenges in Florida's Medicaid program.Impact of audit and feedback on antipsychotic prescribing in schizophrenia.Pharmacotherapy of first episode psychosis in Estonia: comparison with national and international treatment guidelines.Clinical correlates of antipsychotic polytherapy in patients with schizophrenia in Singapore.Quality of life in persons with schizophrenia in out-patient treatment with first- or second-generation antipsychotics.
P2860
Q24811190-6C5DCBA8-CA1F-4C49-905D-D59F36322DF4Q30485065-623B9F8F-FBC0-4913-812D-10BC6EBCB58DQ35707526-6467EDB4-7168-4935-BCD1-7CB0C0A8C39FQ35825831-4335371C-B781-401D-B2DA-604F4DB75EE1Q35826319-17703421-6A54-47FC-BF07-9917B2A19316Q35906545-9816CC80-894E-450E-AF0B-CE84E7AF1C52Q36057820-43933E05-B947-44B0-A479-E7824100EA81Q36905070-5F3AA1C2-58FA-4945-8B7D-32C186877615Q36905083-827D401F-61E3-4ECE-AEFE-F67CB3C59868Q37029622-6447499B-F808-4DEF-A100-4C6F1C91670EQ37162884-3D1C86FA-F0FE-4F2A-BAF5-8E5F192C29E0Q37212118-3AC201AE-254E-47C0-B016-2DE11FAADAC6Q37281587-7E34A3B8-F24D-4190-A9C5-5C36E69B01DCQ37294192-E0C8DE33-42C5-4884-95F1-247FBB23CF71Q37578712-3355F116-06BE-4147-A1E0-EE8110514CD6Q37831352-934B78EE-9253-4048-9777-549BAEBB1C23Q37863093-232504DE-00A3-4534-994C-BD8D327DEEA2Q38950803-5368B6DF-8E0D-4557-8B90-6CCE719FB5CDQ39756918-A360B0C3-9280-4810-96B5-05B616D14AABQ40793932-ED50FC78-8193-4028-A83C-FBD591A699D3Q42180852-9A474606-44B4-4CB0-8CBE-DE8611C7C6E2Q42611657-0A2FD221-BD8B-4841-B213-21ADF736831CQ42615483-C4838DFA-480E-4BA3-BC1B-A0D11A42B649Q42946206-5432C5BA-07D5-41FE-B7DF-A873A996558AQ44263856-19A1049A-55C6-4791-87E3-A06578BC1CBDQ44772154-3D51DA75-BA5D-4EE3-BECC-7EE30E48C5F7Q45078085-EDA4E0EC-EDC0-44ED-B196-67735BFA46FBQ45789228-511569F5-1680-44B9-9F65-D5959991D044Q46721830-A7A0D9C4-E0EC-4DDC-9BB7-2AD96F327D07Q51940717-AA753EA1-9246-4F0C-B6E3-37CE784C1519Q52964770-8AA18408-E3F9-4A1A-A6FD-1E906006B349
P2860
Antipsychotic prescribing practices in the Veterans Healthcare Administration--New York metropolitan region.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Antipsychotic prescribing prac ...... -New York metropolitan region.
@en
Antipsychotic prescribing prac ...... -New York metropolitan region.
@nl
type
label
Antipsychotic prescribing prac ...... -New York metropolitan region.
@en
Antipsychotic prescribing prac ...... -New York metropolitan region.
@nl
prefLabel
Antipsychotic prescribing prac ...... -New York metropolitan region.
@en
Antipsychotic prescribing prac ...... -New York metropolitan region.
@nl
P1476
Antipsychotic prescribing prac ...... -New York metropolitan region.
@en
P2093
Ellen M Weissman
P356
10.1093/OXFORDJOURNALS.SCHBUL.A006924
P407
P577
2002-01-01T00:00:00Z